Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in Finland and in Portugal. It is testing agomelatine oral administration (25 to 50 mg/day) for depression.
In FinlandThis study is completed in South Korea. It is testing aripiprazole for Schizophrenia.
Multiple locations, including ChunchonThis study is completed in South Korea. It is testing aripiprazole for schizophrenia.
In SeoulThis study is completed in the United States. It is testing armodafinil for Schizophrenia.
Multiple locations, including Garden GroveThis study is completed. It is testing asenapine Compared With Olanzapine for schizophrenia.
Remote / onlineThis study is completed. It is testing asenapine Compared With Olanzapine for schizophrenia.
Remote / onlineThis study is completed in the United States, in Bulgaria, in Croatia, .... It is testing asenapine for Bipolarity.
Multiple locations, including AnaheimThis study is completed. It is testing asenapine Treatment for Bipolarity.
Remote / onlineThis study is completed. It is testing asenapine Using an Active Control for schizophrenia.
Location not clearly listedThis study is completed. It is testing asenapine Using an Active Control for schizophrenia.
Location not clearly listedThis study is completed. It focuses on Schizophrenia.
Location not clearly listedThis study is completed. It focuses on Schizophrenia.
Location not clearly listedHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.